Everyone Should Have the Best Diabetes Technologies

Read Annika’s bio I’ve known diabetes all of my life… I was diagnosed with type 1 diabetes (T1D) in 2006 when I was seven years old and my little brother was diagnosed in 2009 when he was 22 months old. Our grandpa also has T1D. When he was diagnosed in 1957 at the age of […]

New Details Emerge from JDRF-Supported Islet Cell Encapsulation Research during 2015 American Diabetes Association (ADA) Scientific Sessions

New Details Emerge from JDRF-Supported Islet Cell Encapsulation Research during 2015 American Diabetes Association (ADA) Scientific Sessions

Cell sources and encapsulation materials are highlighted JDRF-supported researcher Timothy Kieffer talks about the 2015 ADA conference. JDRF’s work to accelerate development of encapsulated islet cell therapies for treatment of type 1 diabetes (T1D) was on display at this year’s ADA conference as three investigators funded by the organization presented new details from their recently […]

2015 American Diabetes Association (ADA) Conference Highlights Efforts to Stop Diabetic Kidney Disease

2015 American Diabetes Association (ADA) Conference Highlights Efforts to Stop Diabetic Kidney Disease

Researchers gain ground in predicting the complication and developing potential therapies See JDRF-supported researcher Ian DeBoer, M.D., talk about the importance of kidney care and T1D. Long-term exposure to high blood-sugar levels put a majority of people with type 1 diabetes (T1D) at risk for dangerous complications that affect the function of vital organs. The […]

Artificial Pancreas (AP) Technology Take the Stage at the 75th Annual American Diabetes Association (ADA) Conference

Artificial Pancreas (AP) Technology Take the Stage at the 75th Annual American Diabetes Association (ADA) Conference

Commercialization of hybrid closed-loop systems, dual-hormone AP therapy and pediatric studies were hot topics Watch video of UVA researcher Stacey Anderson, M.D., talking about the DiAs AP system. The 2015 ADA conference in Boston, MA highlighted the impressive progress that has been made in developing AP technology in less than a decade, and provided a […]

Leading the Charge: Virginia’s Artificial Pancreas System

The University of Virginia’s Diabetes Assistant system is on the road to automate insulin delivery Researchers at the University of Virginia (UVA) have been working for nearly a decade to turn a novel concept called the artificial pancreas (AP) system into working medical technology by adding automation to the pump that will help reduce the […]

Study Aims to Prevent Kidney Damage for T1D

A promising JDRF-funded trial looks at allopurinol—a 50-year-old gout treatment drug—to slow or stop loss of kidney function in people living with Type 1 Diabetes (T1D) The Preventing Early Renal Function Loss in Diabetes (PERL) Consortium is conducting a multi-site, international clinical trial of allopurinol as an intervention for T1D-related kidney disease. Allopurinol is an […]

JDRF Top Research Advances

The past year brought about significant advances in type 1 diabetes (T1D) therapies that are improving how people live with the disease and bringing us closer to a biological cure and universal advances that have helped make this a pivotal moment in the history of T1D research. ENCAPSULATION The JDRF Encapsulation Program funds development of […]

Well-Timed AP Technology Offers Peace of Mind in the UK

A JDRF-funded study at the University of Cambridge showed that an overnight treat-to-range device improved glucose control A recent JDRF-funded study at the University of Cambridge has found that unsupervised, at-home use of a treat-to-range artificial pancreas system can improve blood-glucose control throughout the night and into the next day. You can click on the […]